iShares Genomics Immunology and Healthcare ETF IDNA
37.81 USD -0.61 (-1.59%)
Regular-session close
37.81 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
37.70 Day range 38.85
25.82 52-week range 44.15
- YTD
- +44.37%
- 1 year
- +45.76%
News
benzinga.com Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs The biotech sector has a new catalyst beyond GLP-1 drugs. Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc's (NYSE:MRK) positive Phase 3 results for a personalized mRNA cancer vaccine could revive…
zacks.com Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.
seekingalpha.com IDNA: 3 Catalysts To Watch Closely IDNA jumped 13.53% in one day on 2.8x average volume after three catalysts, including Moderna's and Merck's positive Phase 3 INTerpath-001 data. IDNA trades at a 14.90x forward P/E, implying a 6.7%…
defenseworld.net iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Up 428.3% in January iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA - Get Free Report) was the target of a large growth in short interest during the month of January. As of January 15th, there was short…
seekingalpha.com IDNA: The Cutting Edge Of Medical Science Is A Risky Investment The iShares Genomics Immunology and Healthcare ETF is invested in 49 companies involved in genomics, immunology and bioengineering. Compared with the biotechnology benchmark IBB, IDNA has value…
etftrends.com Disruptive Theme of the Week – Breakthroughs in Medicine Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical…
seekingalpha.com IDNA: Healthcare Dashboard For February This article provides a monthly dashboard with aggregate industry metrics in the healthcare sector. Fast facts on IDNA, a thematic and volatile biotech ETF. We conclude with 10 healthcare stocks…
etftrends.com Disruptive Tech Theme of the Week: 7 Disruptive Themes for 2024 To use a holiday analogy, I have been checking lists and checking them twice to figure out which of next year's top disruptive investment themes are likely to be nice.
etftrends.com VettaFi Voices On: Accessing Disruptive Innovation Good Morning, VettaFi Voices! Disruptive innovation is a popular topic, and it encompasses everything from bitcoin and cryptocurrency to electric vehicles to artificial intelligence.
seekingalpha.com IDNA: Continues To Underperform, But With Long-Term Potential I rate IDNA a Hold due to its focus on biotech stocks with long-term growth potential in a rapidly growing healthcare industry. Despite impressive growth since its inception in 2019, IDNA has…
seekingalpha.com IDNA: Thematic Biotechnology Index Fund Only Suitable For The Long Run Genomic revolution and pharmacogenomics have strong growth prospects that may enable the iShares Genomics Immunology and Healthcare ETF biotech portfolio to generate supernormal growth. In order to…
etftrends.com Thematic Index Lineup Joins VettaFi and the Future Is Bright A decade ago, when the ROBO Global Robotics & Automation Index ETF (ROBO) launched, the U.S. thematic ETF market was nascent, with only a handful of products and minimal assets. However, at the end…
investorplace.com The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.
seekingalpha.com IDNA: Healthcare Dashboard For February Pharmaceuticals and biotechnology still look attractive. Healthcare providers are close to their baseline in both valuation and quality.
zacks.com Will 2023 be the Year of Cathie Wood ETFs? Cathie Wood, famous for the success of Ark Investment???s winning products, had faced a miserable fate in 2022.
seekingalpha.com Can Health Care Stocks Outperform Again In 2023? How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
seekingalpha.com IDNA: Healthcare Dashboard For November The pharmaceutical and biotechnology subsector is undervalued by about 17% relative to 11-year averages. Healthcare equipment and life science tools are overvalued by about 25% regarding the same…
etf.com BlackRock Zeros in on Themed ETFs The category represents a rapidly growing portion of the issuer's lineup.
seekingalpha.com Why Now Could Be The Time To Consider Neuroscience Investments Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in…
investorplace.com 7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher Monkeypox stocks, our topic for today, have had a mostly mixed performance so far in 2022. It is likely, however, that they could benefit from the similar tailwinds enjoyed by companies, such as…
